Biotechnology Companies' Annual Reports & Investor Relations Material

582 Companies

RCUS

Arcus Biosciences

Arcus Biosciences, a clinical-stage biopharmaceutical company headquartered in Hayward, California is advancing the development of innovative cancer therapies. The company is currently focused on s...

Arcus Biosciences Annual Report 2023

Healthcare Biotechnology NYSE 201-500

SLGL

Sol-Gel

Sol-Gel Technologies Ltd., a clinical stage pharmaceutical company based in Israel, is making waves in the dermatological drug products market thanks to its unique microencapsulation delivery syste...

Sol-Gel Annual Report 2023

Healthcare Biotechnology NASDAQ 11-50

AKBA

Akebia Therapeutics

Cambridge-based biopharmaceutical company, Akebia Therapeutics, Inc., has its sights set on developing and selling therapeutics for those suffering from kidney diseases. The firm's primary developm...

Akebia Therapeutics Annual Report 2023

Healthcare Biotechnology NASDAQ 201-500

NBIX

Neurocrine Biosciences

San Diego-based biopharmaceutical company, Neurocrine Biosciences, Inc. has developed and introduced an array of treatment options for neurological, endocrine, and psychiatric disorders. Among its ...

Neurocrine Biosciences Annual Report 2023

Healthcare Biotechnology NASDAQ 501-1000

ARQT

Arcutis Biotherapeutics

Biotherapeutic powerhouse Arcutis Biotherapeutics, Inc., a California-based biopharmaceutical firm, has set its sights on revolutionizing dermatological treatments. With a primary focus on developi...

Arcutis Biotherapeutics Annual Report 2023

Healthcare Biotechnology NASDAQ 51-200

SLNO

Soleno Therapeutics, Inc.

Soleno Therapeutics, a California-based clinical-stage biopharmaceutical company, is dedicated to advancing novel therapeutics for the treatment of rare diseases. Its leading candidate, Diazoxide C...

Soleno Therapeutics, Inc. Annual Report 2023

Healthcare Biotechnology NASDAQ 1-10

ZLAB

Zai Lab Limited

Shanghai-based Zai Lab Limited is making waves in the pharmaceutical industry with its innovative therapies to treat a range of diseases including oncology, autoimmune disorders, infectious disease...

Zai Lab Limited Annual Report 2023

Healthcare Biotechnology NASDAQ 501-1000

REDX

Redx Pharma Plc

Redx Pharma Plc is a biotech company listed on AIM that specializes in discovering and developing targeted medicines to fight cancer and fibrotic disease. Its team of 50 scientists is located at Al...

Redx Pharma Plc Annual Report 2023

Healthcare Biotechnology LSE 11-50

ACR

ACRES Commercial Realty

ACRES Commercial Realty Corp. is a New York-based real estate investment trust (REIT) that focuses on commercial real estate mortgage loans and related debt investments in the United States. The co...

ACRES Commercial Realty Annual Report 2023

Healthcare Biotechnology ASX 11-50

LOGC

LogicBio Therapeutics, Inc.

LogicBio Therapeutics is a biotech company focused on expanding the applications of genetic medicine through targeted delivery platforms. Their proprietary genome editing technology platform, GeneR...

LogicBio Therapeutics, Inc. Annual Report 2020

Healthcare Biotechnology NASDAQ 11-50

PULM

Pulmatrix, Inc.

Lexington-based clinical stage biotech firm Pulmatrix, Inc. is pioneering inhaled therapies for respiratory and other diseases with unmet medical needs in the US. The company is leveraging its inno...

Pulmatrix, Inc. Annual Report 2023

Healthcare Biotechnology NASDAQ 11-50

CGIX

Cancer Genetics, Inc.

Cancer Genetics is a precision and translational medicine company that offers proprietary preclinical test systems through its vivoPharm subsidiary. These test systems are highly valued by the phar...

Cancer Genetics, Inc. Annual Report 2019

Healthcare Biotechnology NASDAQ 51-200

RETA

Reata Pharmaceuticals

Reata Pharmaceuticals, a Texas-based clinical-stage biopharmaceutical company, is making strides in identifying, developing, and commercializing novel therapeutics for patients with serious or life...

Reata Pharmaceuticals Annual Report 2021

Healthcare Biotechnology NASDAQ 201-500

AEZS

AEterna Zentaris Inc.

Aeterna Zentaris, a specialty biopharmaceutical firm, is making strides in the development and commercialization of therapeutics and diagnostic tests. The company's flagship product is Macrilen, an...

AEterna Zentaris Inc. Annual Report 2023

Healthcare Biotechnology TSX 11-50

INO

Inovio Pharmaceuticals

Inovio Pharmaceuticals, Inc. is a leading biotechnology company that specializes in the development of DNA medicines that treat and safeguard individuals from diseases associated with human papillo...

Inovio Pharmaceuticals Annual Report 2023

Healthcare Biotechnology NASDAQ 51-200